期刊文献+

原发性肝癌中FYVE-CENT、Ki-67的表达及意义 被引量:4

Expression and significance of FYVE- CENT and Ki-67 in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨FYVE-CENT和Ki-67抗原在原发性肝癌中表达的意义及其关系。方法采用免疫组织化学法检测50例原发性肝癌及其癌旁和8例正常肝组织中FYVE-CENT和Ki-67表达情况。结果肝癌、癌旁及正常肝脏组织中FYVE-CENT阳性表达率分别为52.0%、78.0%和100.0%,肝癌中FYVE-CENT的阳性表达率明显低于癌旁和肝脏组织,差异均有统计学意义(χ2=7.429,χ2=6.551,P<0.0167)。而Ki-67在三者中的阳性表达率分别是68.0%、42.0%和0,肝癌中Ki-67的阳性表达率显著高于癌旁及肝脏组织(χ2=6.828,P<0.0167;P=0.000)。肝癌组织中,FYVE-CENT和Ki-67的表达呈负相关(r=-0.316,P<0.05)。结论 FYVE-CENT的低表达和Ki-67的高表达与肝癌的发生发展密切相关,在肝癌发展过程中起重要作用。 Objective To investigate the expression of FYVE- CENT and Ki- 67,and reveal their relationship in hepatocellular carcinoma( HCC). Methods En Vision immunohistochemical technique was performed to detect the expression of FYVE- CENT and Ki- 67 in 50 HCC tissues and adjacent non- tumorous tissues( NT) and 8 cases of normal liver tissues. Results In HCC and NT and normal liver tissues,the positive expression rate of FYVE- CENT was 52. 0%,78. 0% and 100. 0%,and that of Ki- 67 was 68. 0%,42. 0% and 0,respectively. The expression of FYVE- CENT in HCC was lower than that in NT and normal liver tissues( χ^2= 7. 429,χ^2= 6. 551,P〈 0. 0167). However,the expression of Ki- 67 in HCC was higher than that in NT and normal liver tissues( χ^2= 6. 828,P〈 0. 0167; P = 0. 000). The expression of FYVE- CENT and Ki- 67 were negative correlation with significant difference( r =- 0. 316,P〈0. 05). Conclusion Down- regulation of FYVE- CENT and up- regulation of Ki- 67 may play a pivotal role in the tumorigenesis and development of HCC.
出处 《临床和实验医学杂志》 2016年第10期969-972,共4页 Journal of Clinical and Experimental Medicine
基金 广东省科技厅科技计划项目基金资助(编号:2010B031600119)
关键词 原发性肝癌 FYVE-CENT KI-67 免疫组织化学 Hepatocellular carcinoma FYVE-CENT Ki-67 Immunohistochemistry
  • 相关文献

参考文献8

  • 1Sagona AP, Nezis IP, Pedersen NM, et al. PtdIns(3 )P controls cytoki-nesis through KIF13A - mediated recruitment of FYVE - CENT to the midbody[ J]. Nat Cell Biol, 2010,12(4) :362 -371.
  • 2Sagona AP, Stenmark H. Cytokinesis and cancer [ J ]. FEBS Lett, 2010,584(12) :2652 -2661.
  • 3Guzman G, Alagiozian - Angelova V, Layden - Ahner JE, et al. p53, Ki - 67, and serum alpha feto - protoin as predictors of hepatocellular carcinoma recurrence in liver transplant patients [ J ]. Mod Pathol, 2005,18:1498 - 1503.
  • 4Hanein S, Martin E, Boukhris A, et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal - recessive spastic paraplegia,including Kjellin syndrome[ J]. Am J Hum Genet, 2008,82(4) :992 - 1002.
  • 5Sagona AP, Nezis IP, Bathe KG, et al. A Tumor - Associated Mutation of FYVE ~ CENT Prevents Its Interaction with Beclin 1 and Interferes with Cytokinesis[J]. PLoS ONE, 2011,6(3) :e17086.
  • 6黄维,阮健,陈逢生,郑大勇,陈锦章.卵巢浆液性腺癌术后组织中Ki-67基因和E-cadherin的表达及意义[J].临床和实验医学杂志,2015,14(16):1344-1347. 被引量:4
  • 7罗旻,曹颖,文安智.肝癌组织中Ki-67表达水平及微血管密度与患者年龄的相关性[J].肿瘤研究与临床,2014,26(5):322-324. 被引量:2
  • 8郑苏苏,沈沪佳,陈晓泓,任正刚,张博恒,殷欣,杜敏,王嘉兴,邱双健.Ki-67与肝细胞癌根治术后早期复发的关系[J].中华消化杂志,2014,34(5):316-320. 被引量:10

二级参考文献38

  • 1王晨,张晓琴,魏荣,吴丽然,李欣,王晶昌.乳腺肿瘤中DNA含量、Ki-67指数、肿瘤微血管密度的定量研究[J].肿瘤研究与临床,2006,18(12):815-818. 被引量:4
  • 2Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown[J]. J Cell Physinl, 2000, 182:311-322.
  • 3Mann CD, Neal CP, Gareea G, et al. Prognostic molecular markers in hepatocellular carcinoma: a systematic review[J]. Eur J Cancer, 2007, 43: 979-992.
  • 4Singhal A, Jayaraman M, Dhanasekaran DN, et al. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence[J]. Crit Rev Oncol Hematol, 2012, 82:116- 140.
  • 5Ito Y, Miyauchi A, Kakudo K, et al. Prognostic significance of Ki-67 labeling index in papillary thyroid carcinoma[J]. World J Surg, 2010, 34: 3015-3021.
  • 6Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma[J].Lancet,2012,379(9822):1245-1255.
  • 7Shah SA,Greig PD,Gallinger S,et al.Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes[J].J Am Coll Surg,2006,202(2):275-283.
  • 8Imamura H,Matsuyama Y,Tanaka E,et al.Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy[J].J Hepatol,2003,38(2):200-207.
  • 9Gerdes J,Dallenbach F,Lennert K,et al.Growth fractions in malignant non Hodgkin's lymphomas(NHL)as determined in situ with the monoclonal antibody Ki 67[J].Hematol Oncol,1984,2(4):365-371.
  • 10King KL,Hwang JJ,Chau GY,et al.Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma [J].J Gastroenterol Hepatol,1998,13(3):273-279.

共引文献13

同被引文献27

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部